The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)

Market Cap	9.12B
Revenue (ttm)	11.37B
Net Income (ttm)	670.52M
Shares Out	31.24M
EPS (ttm)	21.46
PE Ratio	13.60
Forward PE	11.22
Dividend	6.30 (2.16%)
Ex-Dividend Date	Oct 28, 2024

Volume	232,331
Open	305.00
Previous Close	298.20
Day's Range	290.10 - 305.00
52-Week Range	223.50 - 384.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2024

About IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 4,000
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2024, IBNSINA's revenue was 11.37 billion, an increase of 24.61% compared to the previous year's 9.13 billion. Earnings were 670.52 million, an increase of 10.75%.